Cipher Pharmaceuticals (CPH) Competitors

Cronos Group (TSE:CRON) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, community ranking, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

Does the media refer more to CRON or CPH?

In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Cipher Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Cronos Group	Neutral
Cipher Pharmaceuticals	Neutral

Which has more volatility and risk, CRON or CPH?

Cronos Group has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500.

Do analysts prefer CRON or CPH?

Cipher Pharmaceuticals has a consensus target price of C$14.75, indicating a potential upside of 13.99%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Cipher Pharmaceuticals is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cipher Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Does the MarketBeat Community prefer CRON or CPH?

Cipher Pharmaceuticals received 112 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 61.99% of users gave Cipher Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

Company	Underperform	Outperform
Cronos Group	Outperform Votes 69 50.74%	Underperform Votes 67 49.26%
Cipher Pharmaceuticals	Outperform Votes 181 61.99%	Underperform Votes 111 38.01%

Which has preferable earnings & valuation, CRON or CPH?

Cipher Pharmaceuticals has lower revenue, but higher earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$76.86M	8.97	-C$32.78M	-C$0.18	-14.52
Cipher Pharmaceuticals	C$19.03M	12.21	C$11.41M	C$0.91	14.29

Is CRON or CPH more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-42.65%	-4.40%	-3.73%
Cipher Pharmaceuticals	59.92%	17.93%	7.90%

Do insiders & institutionals have more ownership in CRON or CPH?

16.0% of Cronos Group shares are held by institutional investors. Comparatively, 1.4% of Cipher Pharmaceuticals shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Cipher Pharmaceuticals beats Cronos Group on 14 of the 17 factors compared between the two stocks.